Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 367
Filtrar
1.
Sci Adv ; 5(11): eaax9444, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31799397

RESUMEN

Preserving tropical biodiversity is an urgent challenge when faced with the growing needs of countries. Despite their crucial importance for terrestrial ecosystems, most tropical plant species lack extinction risk assessments, limiting our ability to identify conservation priorities. Using a novel approach aligned with IUCN Red List criteria, we conducted a continental-scale preliminary conservation assessment of 22,036 vascular plant species in tropical Africa. Our results underline the high level of extinction risk of the tropical African flora. Thirty-three percent of the species are potentially threatened with extinction, and another third of species are likely rare, potentially becoming threatened in the near future. Four regions are highlighted with a high proportion (>40%) of potentially threatened species: Ethiopia, West Africa, central Tanzania, and southern Democratic Republic of the Congo. Our approach represents a first step toward data-driven conservation assessments applicable at continental scales providing crucial information for sustainable economic development prioritization.


Asunto(s)
Especies en Peligro de Extinción , Extinción Biológica , África , Biodiversidad , Conservación de los Recursos Naturales/métodos , Bases de Datos Factuales , Plantas
2.
Placenta ; 33(11): 933-41, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22999499

RESUMEN

OBJECTIVES: To examine whether syncytin-1 has immune regulatory functions and is carried by human placental exosomes. Further, to examine whether corticotropin-releasing hormone (CRH) can induce the production of syncytin-1. STUDY DESIGN: Human placental exosomes were isolated from placental explant, primary trophoblast and BeWo cell cultures. The presence of exosomes was confirmed by transmission electron microscopy and western blotting. Exosomal protein was probed with 3 separate antibodies targeting syncytin-1. Syncytin-1 immunosuppression was tested, using either a syncytin-1 recombinant ectodomain protein or a synthetic peptide with the human syncytin-1 immunosuppressive domain sequence, in an in vitro human blood culture system immune challenged with LPS or PHA. The inhibition of cytokine production by syncytin-1 was determined by ELISA of TNF-α, IFN-γ and CXCL10. BeWo cells were stimulated with CRH or vehicle for 24 h. mRNA and Protein was extracted from the cells for real-time PCR and western blotting analysis while exosomes were extracted from conditioned media for analysis by western blotting. RESULTS: Protein expression of syncytin-1 was detected in exosomes isolated from placental explants, primary trophoblast and BeWo cell cultures. Syncytin-1 recombinant ectodomain was also shown to inhibit the production of the Th1 cytokines TNF-α and IFN-γ as well as the chemokine, CXCL10 in human blood cells. Finally, this study showed that syncytin-1 can be stimulated by CRH. CONCLUSIONS: The presence of syncytin-1 in placental exosomes provides a mechanism for syncytin-1 to reach and interact with target cells of the maternal immune system and represents a novel mechanism of endogenous retroviral mediated immunosuppression that may be relevant for maternal immune tolerance.


Asunto(s)
Citocinas/metabolismo , Exosomas/metabolismo , Regulación de la Expresión Génica , Productos del Gen env/metabolismo , Tolerancia Inmunológica , Leucocitos Mononucleares/metabolismo , Placenta/metabolismo , Proteínas Gestacionales/metabolismo , Adulto , Transporte Biológico , Línea Celular , Células Cultivadas , Hormona Liberadora de Corticotropina/metabolismo , Citocinas/genética , Retrovirus Endógenos/metabolismo , Exosomas/inmunología , Exosomas/ultraestructura , Exosomas/virología , Femenino , Productos del Gen env/química , Productos del Gen env/genética , Humanos , Leucocitos Mononucleares/inmunología , Lipopolisacáridos , Fitohemaglutininas , Placenta/inmunología , Placenta/ultraestructura , Placenta/virología , Embarazo , Proteínas Gestacionales/química , Proteínas Gestacionales/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Técnicas de Cultivo de Tejidos
4.
J Neuroendocrinol ; 20(6): 700-4, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18601692

RESUMEN

This paper will document the early scientific observations that kindled my neuroendocrinological interest in pre-eclampsia, a life-threatening disease that affects both mother and baby. My interest in this subject started with the placental origin of melanotrophin activity, moving on, through corticotrophin-releasing factor and its binding protein, to a tachykinin modified specifically in the placenta by phosphocholine, a post-translational moiety normally used by parasites to avoid immune surveillance and rejection. This work may finally have led to an understanding of the identity of the elusive placental factor that, whilst attempting to compensate for the poor implantation of the placenta, causes the many symptoms seen in the mother during pre-eclampsia.


Asunto(s)
Sistemas Neurosecretores/fisiología , Placenta/metabolismo , Preeclampsia/metabolismo , Animales , Femenino , Humanos , Sistema Inmunológico/fisiología , Neuroquinina B/metabolismo , Fosforilcolina/metabolismo , Embarazo
5.
Eur J Endocrinol ; 157(3): 279-84, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17766709

RESUMEN

OBJECTIVE: Placental corticotropin-releasing factor (CRF) affects myometrial contractility and the secretion of several uterotonins such as prostaglandins (PGs); however, the activity of CRF is counteracted by CRF-binding protein (CRF-BP). At term and pre-term labor, CRF levels in maternal plasma are highest whereas those of CRF-BP are falling, and the cause of this fall is unknown. Thus, in this study, we investigated the effect of PG administration for labor induction on maternal plasma CRF and CRF-BP concentrations. DESIGN: Maternal plasma CRF and CRF-BP levels were assayed before and after (2 h later) induction of labor by intracervical administration of prostaglandin E(2) (PGE(2)), and at delivery in a group of healthy post-term pregnancies (n=18). Controls were women at term out of labor (n=22), who subsequently progressed to deliver a healthy singleton baby. METHODS: CRF was measured by two-site immunoradiometric assay, and CRF-BP was assayed by radioimmunoassay. RESULTS: Maternal plasma CRF levels were significantly (P<0.0001) lower and CRF-BP significantly (P<0.0005) higher in post-term than in term pregnancies. With respect to induction of labor, 2 mg PGE(2) were sufficient to increase maternal plasma CRF levels at delivery (P<0.005). While 0.5 mg PGE(2) significantly decreased maternal plasma CRF-BP levels at delivery (P<0.001), 2.0 mg PGE(2) significantly reduced CRF-BP concentrations both after 2 h (P<0.05) and at delivery (P<0.0001). CONCLUSIONS: In the light of the well-known stimulation of prostaglandin release by CRF, these data suggest a positive feedback effect of PGE(2) on maternal CRF release during induced labor.


Asunto(s)
Proteínas Portadoras/sangre , Hormona Liberadora de Corticotropina/sangre , Dinoprostona/administración & dosificación , Trabajo de Parto Inducido/métodos , Oxitócicos/administración & dosificación , Embarazo Prolongado/sangre , Adulto , Dinoprostona/metabolismo , Retroalimentación Fisiológica/efectos de los fármacos , Femenino , Humanos , Recién Nacido , Oxitócicos/metabolismo , Parto/sangre , Parto/efectos de los fármacos , Embarazo , Contracción Uterina/efectos de los fármacos , Contracción Uterina/metabolismo
6.
Heart ; 92(12): 1773-8, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16807273

RESUMEN

BACKGROUND: The pathological effects and the mechanisms of action of intracoronary administration of ethanol for alcohol septal ablation (ASA) for the management of hypertrophic obstructive cardiomyopathy (HOCM) are unknown. METHODS: We examined surgical specimens and, in one case, autopsy specimens from four patients who underwent surgical septal myectomy 2 days to 14 months after unsuccessful ASA. RESULTS: Pathological examination early after ASA showed coagulative necrosis of both the myocardium and the septal perforator arteries. Affected arteries were distended and occluded by necrotic intraluminal debris, without platelet-fibrin thrombi. Late after unsuccessful ASA, excised septal tissue was heterogeneous, containing a region of dense scar, and adjacent tissue containing viable myocytes and interspersed scar. CONCLUSIONS: Intracoronary administration of ethanol in patients with HOCM causes acute myocardial infarction with vascular necrosis. The coagulative necrosis of the arteries, their distension by necrotic debris and the absence of platelet-fibrin thrombi distinguish ethanol-induced infarction from that caused by atherosclerotic coronary artery disease. The direct vascular toxicity of ethanol may be an important aspect of the mechanism of successful ASA.


Asunto(s)
Cardiomiopatía Hipertrófica/terapia , Etanol/administración & dosificación , Soluciones Esclerosantes/administración & dosificación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Cardiomiopatía Hipertrófica/patología , Etanol/efectos adversos , Femenino , Humanos , Inyecciones Intralesiones , Masculino , Persona de Mediana Edad , Soluciones Esclerosantes/efectos adversos , Insuficiencia del Tratamiento
7.
Occup Med (Lond) ; 56(3): 162-72, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16641501

RESUMEN

The current approach to medical management of irradiated patients begins with early diagnosis of radiation injury. Medical assessment of radiation dose is based on event history, symptomatology and laboratory results, with emphasis on time to emesis and lymphocyte depletion kinetics. Dose assessment provides a basis for early use of haematopoietic growth factors that can shorten the period of neutropaenia for patients with acute radiation syndrome. Assessments of haematopoietic, gastrointestinal and cutaneous syndromes have improved in recent years, but treatment options remain limited. Selected examples of current developments are presented.


Asunto(s)
Traumatismos por Radiación/terapia , Accidentes de Trabajo , Factores Estimulantes de Colonias/uso terapéutico , Trasplante de Células Madre Hematopoyéticas , Humanos , Infecciones Oportunistas/terapia , Dosis de Radiación , Traumatismos por Radiación/diagnóstico , Traumatismos por Radiación/etiología , Liberación de Radiactividad Peligrosa
8.
J Clin Endocrinol Metab ; 89(9): 4673-7, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15356079

RESUMEN

In the present study we measured maternal plasma concentrations of two placental neurohormones, corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP), in 58 at-risk pregnant women consecutively enrolled between 28 and 29 wk of pregnancy to evaluate whether their evaluation may predict third trimester-onset preeclampsia (PE). The statistical significance was assessed by t test. The cut-off points for defining altered CRF and CRF-BP levels for prediction of PE were chosen by receiving operator characteristics curve analysis, and the probability of developing PE was calculated for several combinations of hormone testing results. CRF and CRF-BP levels were significantly (both P < 0.0001) higher and lower, respectively, in the patients (n = 20) who later developed PE than in those who did not present PE at follow-up. CRF at the cut-off 425.95 pmol/liter achieved a sensitivity of 94.8% and a specificity of 96.9%, whereas CRF-BP at the cut-off 125.8 nmol/liter combined a sensitivity of 92.5% and a specificity of 82.5% as single markers for prediction of PE. The probability of PE was 34.5% in the whole study population, 93.75% when both CRF and CRF-BP levels were changed, and 0% if both hormone markers were unaltered. The measurement of CRF and CRF-BP levels may add significant prognostic information for predicting PE in at-risk pregnant women.


Asunto(s)
Proteínas Portadoras/sangre , Hormona Liberadora de Corticotropina/sangre , Preeclampsia/sangre , Adulto , Femenino , Humanos , Preeclampsia/diagnóstico , Embarazo , Probabilidad , Estudios Prospectivos
9.
J Mol Endocrinol ; 31(3): 341-7, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14664698

RESUMEN

The endocrine placenta has a dilemma; it shares the foetal circulation and yet it needs to secrete active peptide hormones into the maternal circulation to control her metabolism to meet the demands of the growing foetus. Simultaneously, it needs to allow the endocrine systems of the foetus to develop independently. This Article will describe how peptide hormones are processed from inactive intermediates and will propose a hypothesis of how the placenta has revised this process to protect the foetus from the potentially damaging affects of these products.


Asunto(s)
Hormona Liberadora de Corticotropina/metabolismo , Feto/metabolismo , Intercambio Materno-Fetal/fisiología , Neuroquinina B/metabolismo , Placenta/metabolismo , Animales , Carboxipeptidasa B/metabolismo , Sistema Endocrino/metabolismo , Femenino , Humanos , Hormonas Placentarias/metabolismo , Embarazo
10.
J Clin Endocrinol Metab ; 88(5): 2164-70, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12727971

RESUMEN

Neurokinin (NK) B is a member of the tachykinin family of neurotransmitters, exerting hypotensive or hypertensive effects in the mammalian vasculature through synaptic release from peripheral neurons, according to either NK(1) and NK(2) or NK(3) receptor subtype expression, respectively. There is recent evidence that NKB is expressed by the syncytiotrophoblast of the human placenta, an organ that is not innervated. We hypothesized that NKB is a paracrine modulator of tone in the fetal placental circulation. We tested this hypothesis using the in vitro perfused human placental cotyledon. Our data show that NKB is a dilator of the fetal vasculature, causing a maximal 25.1 +/- 4.5% (mean +/- SEM; n = 5) decrease in fetal-side arterial hydrostatic pressure (5- microM NKB bolus; effective concentration in the circulation, 1.89 nM) after preconstriction with U-46619. RT-PCR demonstrated the presence of mRNA for NK(1) and NK(2) tachykinin receptors in the placenta. Using selective receptor antagonists, we found that NKB-induced vasodilation is through the NK(1) receptor subtype. We found no evidence for the involvement of either nitric oxide or prostacyclin in this response. This study demonstrates a paracrine role for NKB in the regulation of fetal placental vascular tone.


Asunto(s)
Feto/irrigación sanguínea , Neuroquinina B/fisiología , Placenta/irrigación sanguínea , Vasodilatación , Presión Sanguínea/efectos de los fármacos , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/metabolismo , Inhibidores de la Ciclooxigenasa/farmacología , Inhibidores Enzimáticos/farmacología , Epoprostenol/fisiología , Indometacina/farmacología , NG-Nitroarginina Metil Éster/farmacología , Neuroquinina B/sangre , Neuroquinina B/farmacología , Óxido Nítrico/fisiología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Placenta/química , Receptores de Neuroquinina-1/genética , Receptores de Neuroquinina-1/fisiología , Receptores de Neuroquinina-2/genética , Receptores de Neuroquinina-2/fisiología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Vasodilatación/efectos de los fármacos
11.
J Neuroendocrinol ; 15(6): 572-85, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12716408

RESUMEN

This study used the novel approach of statistical modelling to investigate the control of hypothalamic-pituitary-adrenal (HPA) axis and quantify temporal relationships between hormones. Two experimental paradigms were chosen, insulin-induced hypoglycaemia and 2 h transport, to assess differences in control between noncognitive and cognitive stimuli. Vasopressin and corticotropin-releasing hormone (CRH) were measured in hypophysial portal plasma, and adrenocorticotropin hormone (ACTH) and cortisol in jugular plasma of conscious sheep, and deconvolution analysis was used to calculate secretory rates, before modelling. During hypoglycaemia, the relationship between plasma glucose and vasopressin or CRH was best described by log10 transforming variables (i.e. a positive power-curve relationship). A negative-feedback relationship with log10 cortisol concentration 2 h previously was detected. Analysis of the "transport" stimulus suggested that the strength of the perceived stimulus decreased over time after accounting for cortisol facilitation and negative-feedback. The time course of vasopressin and CRH responses to each stimulus were different However, at the pituitary level, the data suggested that log10 ACTH secretion rate was related to log10 vasopressin and CRH concentrations with very similar regression coefficients and an identical ratio of actions (2.3 : 1) for both stimuli. Similar magnitude negative-feedback effects of log10 cortisol at -110 min (hypoglycaemia) or -40 min (transport) were detected, and both models contained a stimulatory relationship with cortisol at 0 min (facilitation). At adrenal gland level, cortisol secretory rates were related to simultaneously measured untransformed ACTH concentration but the regression coefficient for the hypoglycaemia model was 2.5-fold greater than for transport. No individual sustained maximum cortisol secretion for longer than 20 min during hypoglycaemia and 40 min during transport. These unique models demonstrate that corticosteroid negative-feedback is a significant control mechanism at both the pituitary and hypothalamus. The amplitude of HPA response may be related to stimulus intensity and corticosteroid negative-feedback, while duration depended on feedback alone.


Asunto(s)
Corticoesteroides/metabolismo , Retroalimentación Fisiológica/fisiología , Hipoglucemia/metabolismo , Sistema Hipotálamo-Hipofisario/metabolismo , Modelos Estadísticos , Sistema Hipófiso-Suprarrenal/metabolismo , Estrés Psicológico/metabolismo , Corticoesteroides/sangre , Hormona Adrenocorticotrópica/sangre , Hormona Adrenocorticotrópica/metabolismo , Animales , Hormona Liberadora de Corticotropina/sangre , Hormona Liberadora de Corticotropina/metabolismo , Femenino , Hidrocortisona/sangre , Hidrocortisona/metabolismo , Ovinos , Vasopresinas/sangre , Vasopresinas/metabolismo
12.
Endocr Res ; 28(4): 589-95, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12530668

RESUMEN

As previous work had shown that extreme N-terminal fragments of the ACTH precursor pro-opiomelanocortin (POMC) not containing gamma-melanotropin (gamma-MSH) were active adrenal mitogens but an antiserum raised against gamma-MSH paradoxically also inhibited adrenal growth we proposed that the adrenal mitogen is processed from pro-gamma-MSH by a neurally controlled protease at the growing adrenal. To this end we have characterised a novel serine protease (named adrenal secretory protease (AsP) as Psort predicted a leader motif) which is expressed at the glomerulosa/fasciculata boundary where mitosis takes place. The expression of AsP was also found to be essential for mitosis of the adrenal cortical tumor Y1 cell-line in POMC containing media and 3D homology modeling revealed the presence of a catalytic pocket flanked by the classical His/Asp/Ser motifs. An usual feature of the model was a cluster of arginine residues on the underside of the protease suggesting that this basically charged face would tend to retain it on the cell surface on secretion-immunocytochemistry using an antiserum raised against a synthetic peptide spanning residues 1-25 of AsP showed that this was the case for Y1 cells. Specificity of AsP (affinity purified from Y1 media) was demonstrated by its inability to cleave model substrates for either trypsin or pro-hormone converting enzymes but was able to cleave an internally quenched POMC (44-55) model peptide. Interestingly mass spectral analysis of products of the latter predicts that the protease cleaves between the bond between Val52 and Met53 suggesting the natural adrenal mitogen is POMC (1-52).


Asunto(s)
Corteza Suprarrenal/enzimología , Glándulas Suprarrenales/crecimiento & desarrollo , Proopiomelanocortina/metabolismo , Serina Endopeptidasas/metabolismo , Glándulas Suprarrenales/enzimología , Animales , Clonación Molecular , Humanos , Modelos Biológicos , Serina Endopeptidasas/genética
13.
Endocr Res ; 28(4): 669-73, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12530681

RESUMEN

In comparison to the embryo, very little work has been carried out on the expression and role of Hox genes in the adult animal. An expression profile of all 39 vertebrate Hox genes on a select panel of adult human tissues reveals that in fact these genes are widely expressed throughout the adult human and a colinear pattern of expression is displayed similar to that of the developing embryo. Of particular interest is the abundance of Hox genes that are expressed within the adult adrenal gland. Adrenal cortical cells are continuously renewed to sustain production of zonal steroids. Cell proliferation occurs at the periphery of the cortex and cells are then displaced centripetally, phenotypically switching as they migrate through the gland before undergoing apoptosis at the zona reticularis/medullary boundary. It is still unclear which mechanisms cause the cells to differentiate as they cross the zonal boundaries and we hypothesise that Hox genes may be involved in the phenotypic switching of the adrenocortical cells. In situ hybridisation experiments were carried out on adult rat adrenal gland sections and Hox gene expression was localized within the zonal borders, coinciding with the localization of cells that undergo phenotypic differentiation, and thus supporting our hypothesis that Hox genes may be involved in the phenotypic switching of the adrenocortical cells. As in the developing embryo, the genes display colinear expression with the 3' Hox genes being expressed within the outer gland and the 5' genes within the inner zones.


Asunto(s)
Glándulas Suprarrenales/fisiología , Expresión Génica , Genes Homeobox , Animales , Hibridación in Situ , Masculino , Ratas , Ratas Wistar , Distribución Tisular
14.
Gut ; 49(5): 656-64, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11600468

RESUMEN

AIM: We evaluated the effect of coadministration of sulphasalazine, mesalamine, and balsalazide on the pharmacokinetics and pharmacodynamics of azathioprine and 6-mercaptopurine. METHODS: Thirty four patients with Crohn's disease receiving azathioprine or 6-mercaptopurine were enrolled in an eight week non-randomised parallel group drug interaction study and treated with mesalamine 4 g/day, sulphasalazine 4 g/day, or balsalazide 6.75 g/day. The primary outcome measure was the occurrence of clinically important leucopenia during the study, defined separately as total leucocyte counts < 3.0 x 10(9)/l and < or = 3.5 x 10(9)/l. Whole blood 6-thioguanine nucleotide concentrations were determined. RESULTS: Three patients could not be evaluated for the primary outcome measure. In the remaining 31 patients, the frequency of total leucocyte counts < 3.0 and < or = 3.5 were: 1/10 and 5/10 in the mesalamine group; 1/11 and 6/11 in the sulphasalazine group; and 0/10 and 2/10 in the balsalazide group. There were significant increases in mean whole blood 6-thioguanine nucleotide concentrations from baseline at most time points in the mesalamine and sulphasalazine groups but not in the balsalazide group. CONCLUSIONS: In patients with Crohn's disease receiving azathioprine or 6-mercaptopurine, coadministration of mesalamine, sulphasalazine, and possibly balsalazide results in an increase in whole blood 6-thioguanine nucleotide concentrations and a high frequency of leucopenia.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Inmunosupresores/efectos adversos , Leucopenia/inducido químicamente , Adulto , Ácidos Aminosalicílicos/efectos adversos , Análisis de Varianza , Azatioprina/efectos adversos , Distribución Binomial , Cromatografía Líquida de Alta Presión , Intervalos de Confianza , Interacciones Farmacológicas , Femenino , Humanos , Leucopenia/metabolismo , Masculino , Mercaptopurina/efectos adversos , Mesalamina/efectos adversos , Metiltransferasas/sangre , Fenilhidrazinas , Sulfasalazina/efectos adversos , Tioguanina/análisis
15.
Gut ; 49(5): 665-70, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11600469

RESUMEN

BACKGROUND: Measurement of 6-thioguanine nucleotide concentrations may be useful for optimising treatment with azathioprine and 6-mercaptopurine. METHODS: We conducted a study of 170 patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine to determine the relationship between 6-thioguanine nucleotide concentrations and both disease activity, as measured by the inflammatory bowel disease questionnaire (active disease < 170, remission > or = 170) and leucopenia. Blood was submitted for whole blood 6-thioguanine nucleotide concentration and leucocyte count. RESULTS: Mean (SD) inflammatory bowel disease questionnaire score was 176 (32). There was no correlation between inflammatory bowel disease questionnaire scores and 6-thioguanine nucleotide concentrations (r(s) = -0.09, p = 0.24). Median 6-thioguanine nucleotide concentrations in 56 patients with active disease and 114 patients in remission were similar (139 v 131 pmol/8 x 10(8) red blood cells; p = 0.26). There was no correlation between 6-thioguanine nucleotide concentrations and leucocyte counts. CONCLUSIONS: In patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine, 6-thioguanine nucleotide concentrations did not correlate with disease activity, as measured by the inflammatory bowel disease questionnaire, or leucocyte count. These findings are discrepant with most previous studies, possibly due to selection of responding patients who tolerated the medications. A prospective, randomised, dose optimisation trial using 6-thioguanine nucleotide concentrations is warranted.


Asunto(s)
Azatioprina/sangre , Inmunosupresores/sangre , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Metiltransferasas/sangre , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Azatioprina/uso terapéutico , Femenino , Humanos , Inmunosupresores/uso terapéutico , Enfermedades Inflamatorias del Intestino/sangre , Leucopenia/inducido químicamente , Masculino , Mercaptopurina/sangre , Mercaptopurina/uso terapéutico , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Estadísticas no Paramétricas
16.
Placenta ; 22(8-9): 681-7, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11597188

RESUMEN

We have performed differential display and bioinformatic database mining of the placenta, in an attempt to find novel diagnostic markers of pathological pregnancies. We have identified a full-length cDNA encoding the preproprotein of pregnancy associated plasma protein-E (PAPP-E); a putative metalloprotease, of 1790-residues with a putative 21-residue signal peptide. An alternatively spliced mRNA was found to encode an 826-residue precursor protein corresponding to the N-terminus of PAPP-E. Both PAPP-E variants were found to be co-expressed abundantly in the placenta and non-pregnant mammary gland with low expression in the kidney, foetal brain and pancreas. Analysis of the predicted proteins suggests that the longer variant be targeted to the nucleus while the shorter variant is secreted extracellularly. Gene structure analysis revealed that PAPP-E was encoded on 23 exons on chromosome 1 and its splice variant on the first five same exons. The discovery of the PAPP-E variants will help in the deciphering of the physiology of this new family of metzincins in not only the placenta during pregnancy but also the mammary gland in breast cancer. The new PAPP-E variants could have the potential for the diagnosis of pathological pregnancies including trisomies such as Down's syndrome.


Asunto(s)
Empalme Alternativo , Endopeptidasas , Proteínas Gestacionales/genética , Proteína Plasmática A Asociada al Embarazo , Secuencia de Aminoácidos , Mama/química , Clonación Molecular , ADN Complementario/química , Femenino , Humanos , Hibridación in Situ , Datos de Secuencia Molecular , Placenta/química , Embarazo , Proteínas Gestacionales/análisis , Proteínas Gestacionales/química , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN , Distribución Tisular
17.
Hosp Med ; 62(6): 343-6, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11436440

RESUMEN

Pre-eclampsia, a life-threatening disease unique to pregnancy, has been called a disease of theories. To date, there has been no widely accepted predictive test or therapeutic intervention to prevent or delay pre-eclampsia. The discovery of a new placental hormone, neurokinin B, may finally help to answer some of the past mysteries.


Asunto(s)
Neuroquinina B/fisiología , Preeclampsia/etiología , Presión Sanguínea/efectos de los fármacos , Femenino , Humanos , Placenta/irrigación sanguínea , Placenta/química , Placenta/metabolismo , Preeclampsia/terapia , Embarazo , Receptores de Taquicininas/análisis
18.
Cell ; 105(7): 903-12, 2001 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-11439186

RESUMEN

The adrenal gland requires stimuli from peptides derived from the ACTH precursor, pro-opiomelanocortin (POMC), to maintain its tonic state. Studies have proposed that a specific postsecretional cleavage of the nonmitogenic N-terminal 16 kDa fragment, also known as pro-gamma-melanotropin (pro-gamma-MSH), is required, releasing shorter fragments that promote adrenal growth. Here, we provide evidence for this hypothesis by the cloning and characterization of a serine protease that is upregulated during growth of the adrenal cortex. It is expressed exclusively in the outer adrenal cortex, the site of cell proliferation, and in the Y1 adrenal cell line. We also show that it is required for growth of Y1 cells, remains bound to the cell surface, and cleaves its substrate, pro-gamma-MSH, at a specific bond.


Asunto(s)
Corteza Suprarrenal/crecimiento & desarrollo , Glándulas Suprarrenales/crecimiento & desarrollo , Fragmentos de Péptidos/metabolismo , Proopiomelanocortina/metabolismo , Serina Endopeptidasas/metabolismo , Corteza Suprarrenal/efectos de los fármacos , Corteza Suprarrenal/metabolismo , Glándulas Suprarrenales/efectos de los fármacos , Glándulas Suprarrenales/metabolismo , Adrenalectomía , Secuencia de Aminoácidos , Animales , Aprotinina/farmacología , Secuencia de Bases , Línea Celular , Clonación Molecular , Hibridación in Situ , Masculino , Hormonas Estimuladoras de los Melanocitos/metabolismo , Ratones , Microscopía Fluorescente , Modelos Moleculares , Datos de Secuencia Molecular , Ratas , Alineación de Secuencia , Serina Endopeptidasas/química , Serina Endopeptidasas/genética , Inhibidores de Serina Proteinasa/farmacología
19.
J Chromatogr B Biomed Sci Appl ; 757(1): 1-9, 2001 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-11419732

RESUMEN

The conversion of the cytotoxic and immunosuppressive 6-mercaptopurine (6MP) to the active 6-thioguanine nucleotides (6TGN) is necessary for clinical efficacy of 6MP and its prodrug azathioprine. Another metabolite, 6-methylmercaptopurine nucleotide (6MMPN), is formed via a competing pathway by thiopurine methyl transferase. The concentrations of 6TGN and 6MMPN are measured in washed erythrocytes as a surrogate to the intracellular levels of these metabolites in the target tissues. Analysis of 6TGN and 6MMPN in multi-center clinical studies is more complicated because of the requirement to wash erythrocytes. In this investigation, we found no differences in the concentrations of 6TGN and 6MMPN in blood versus washed erythrocytes in samples obtained from patients taking therapeutic doses of oral 6MP or azathioprine for inflammatory bowel disease. We concluded that whole blood could be used for the analysis of these analytes, thus saving sample preparation time. We also found that the erythrocyte 6TGN concentration in blood at ambient temperature declined 2-4% per day, a loss that can be avoided by shipping blood samples frozen. The loss of 6TGN in blood stored at approximately -80 degrees C was 1% after 1 week and 12% after 24 weeks, indicating the analyte was moderately stable. 6MMPN in blood did not significantly change after 24 weeks of storage at approximately -80 degrees C. In addition, the sensitivity of the 6TGN assay was improved by modifying the HPLC conditions, which made the method more suitable for quantifying low levels of 6TGN in human intestinal biopsy samples and blood.


Asunto(s)
Mercaptopurina/análogos & derivados , Mercaptopurina/sangre , Tioguanina/sangre , Cromatografía Líquida de Alta Presión , Humanos , Enfermedades Inflamatorias del Intestino/sangre , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Mercaptopurina/uso terapéutico , Reproducibilidad de los Resultados , Espectrometría de Fluorescencia , Tioguanina/uso terapéutico
20.
Mol Phylogenet Evol ; 19(2): 259-76, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11341808

RESUMEN

The relationship between the angiosperm families Apiaceae and Araliaceae (order Apiales) has been difficult to resolve, due in large part to problems associated with taxa characterized by a mixture of features typical of both families. Among such confounding groups are the araliads Delarbrea, Pseudosciadium, Myodocarpus, Mackinlaya, and Apiopetalum and many members of Apiaceae subfamily Hydrocotyloideae. Traditional systems have often envisioned these taxa as phyletic intermediates or bridges between the two families. To reevaluate the phylogenetic position of the "intermediate" araliad genera, molecular data were collected from nuclear (rDNA ITS) and plastid (matK) sequences from a complete or near-complete sampling of species in each genus. When analyzed with samples representing the other major clades now recognized within Apiales, results confirm and expand the findings of previously published studies. The five araliad "intermediates" are placed within two well-supported clades clearly segregated from the "core" groups of both Apiaceae and Araliaceae. These segregate clades closely parallel traditional definitions of the araliad tribes Myodocarpeae (Delarbrea, Pseudosciadium, and Myodocarpus) and Mackinlayeae (Mackinlaya and Apiopetalum), and relationships among the species within these clades are largely supported by morphological and anatomical data. Based on these results, Myodocarpeae and Mackinlayeae may best be treated as distinct families. This approach would render four monophyletic groups within Apiales, to which a fifth, Pittosporaceae, cannot at present be excluded. Sampling of taxa from Hydrocotyloideae remains preliminary, but results confirm previous studies indicating the polyphyly of this subfamily: hydrocotyloid taxa may be found in no fewer than three major clades in Apiales.


Asunto(s)
Magnoliopsida/genética , Filogenia , ADN de Plantas/química , ADN de Plantas/genética , ADN Espaciador Ribosómico/genética , Endorribonucleasas/genética , Evolución Molecular , Magnoliopsida/clasificación , Datos de Secuencia Molecular , Nucleotidiltransferasas/genética , ARN Ribosómico/genética , Análisis de Secuencia de ADN
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA